HOSPITAL UNIVERSITARIO DE GETAFE
Departamento
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (29)
2023
-
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research, Vol. 24, Núm. 1
-
Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778
-
Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation
Intensive Care Medicine
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Preconfigured analytical profiles for the management of patients with heart failure: a consensus-driven study
REC: CardioClinics, Vol. 58, Núm. 3, pp. 219-227
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
2022
-
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 4
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 13
-
Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection
Biomedicine and Pharmacotherapy, Vol. 154
-
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
The European respiratory journal, Vol. 59, Núm. 2
-
ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 1
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection
Frontiers in Immunology, Vol. 13
-
One-year mortality after ICU admission due to COVID-19 infection
Intensive Care Medicine
-
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
The Lancet Regional Health - Europe, Vol. 18
2021
-
CIBERESUCICOVID: A strategic project for a better understanding and clinical management of COVID-19 in critical patients
Archivos de Bronconeumologia
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
Scientific Reports, Vol. 11, Núm. 1